How does the Pivka inhibitor interfere with the one-stage prothrombin time?

Area of Science:

• Biochemistry
• Hematology
• Clinical Chemistry

Background:

• Vitamin K deficiency can lead to the production of inactive clotting factors.
• Pivka proteins (proteins induced by vitamin K absence) are biomarkers associated with vitamin K deficiency or antagonism.
• Accurate measurement of coagulation factors is crucial for diagnosing and managing bleeding disorders.

Purpose of the Study:

• To evaluate the influence of Pivka inhibitor on thromboplastin sensitivity using different assays.
• To determine the factors affecting the inhibitor's impact on coagulation tests.
• To assess the possibility of correcting for Pivka inhibitor interference in coagulation analysis.

Main Methods:

• Selection of thromboplastins with varying sensitivity to Pivka inhibitor (Thrombotest and Normotest).
• Analysis of coagulation activity across different sample sizes and packed cell volumes.
• Investigation of interference with ratio method standardization.

Main Results:

• The Pivka inhibitor's influence was more pronounced with larger sample sizes and lower packed cell volumes.
• Satisfactory correction for the Pivka inhibitor's effect was achievable.
• The inhibitor accounted for variations in coagulation activity across different assays and interfered with ratio standardization.

Conclusions:

• Pivka inhibitor significantly impacts thromboplastin sensitivity in coagulation assays.
• Correction methods can effectively mitigate the interference of Pivka inhibitor.
• Understanding Pivka inhibitor's role is essential for accurate coagulation testing and standardization.